"Catenion’s approach to assessing risk and value on both a project and portfolio level goes way beyond what is usually discussed in senior executive teams. It has allowed us to create a very solid foundation of information, which is the key to understanding the portfolio. Their process and independent points of view have greatly helped our Executive Management Board take difficult decisions during a challenging post–merger review of the portfolio, and going forward we have decided to implement their approach as the framework for us to manage our portfolio."
Vincent Aurentz
Executive Vice President
Business Development and Portfolio Management
Merck Serono
Catenion usually works for senior executives at board level or reporting to board members on issues of high strategic impact.
Clients choose us over the competition for two reasons:
The high number of repeat engagements is testimony to the quality of our work.
Recent client engagements included the following topics (click to read more about the anonymised case studies):
Post–Merger Portfolio Analysis and Implementation Support for a member of the executive management team of global pharmaceutical company
Asset Valuation in Neurology for a global head of strategic marketing for a major player in neurology market
Strategy Development for the CEO of a European mid–sized company
Redesigning an R&D Organisation to be Consistent With the New Company strategy for an executive board member for R&D, global pharmaceutical company
Assessment of the Innovation Model of the Research Operations of a Global Pharmaceutical Player for a global head of research of a top pharmaceutical organisation
Launch Preparation in Oncology for a Global Head of Strategic Marketing for a major player in oncology market
Review of Personalised Medicine as a Business Model for the CEO of a Global Healthcare Company